*This webinar is part of CGCC member company Morgan Lewis’ “Continuing Evolution of US-China Relations, 2023 and Beyond” event series*
CLICK HERE to RSVP
About the Event:
US issuers should consider tailoring their risk factors to address their business relating to China and benchmark these risk factors against their peers. Reliance on generic risk factors when doing business internationally may not properly inform investors of matters an issuer may face when engaging in certain China-related activities, and the US Securities and Exchange Commission (SEC) discourages such boilerplate disclosure. In this session, our team of SEC regulation, corporate governance, and US-China policies lawyers will highlight several key areas for your risk factor disclosure considerations. A checklist will be shared with those who join the session or who would like to have a separate discussion with our team.
美国上市公司应该考虑根据其与中国相关的业务相应披露风险因素，并将这些风险因素与其同行进行比较。开展国际业务的公司若仍旧使用一般性风险因素模板可能无法准确地告知投资者发行人在从事某些与中国相关的活动时可能面临的问题，美国证券交易委员会（SEC）也不鼓励此类模板式的披露。在本次研讨会中，我们的SEC监管、公司治理和中美政策律师团队将重点介绍几个关键领域，以供您考虑风险因素披露。我们将与参加会议或希望与我们团队进行单独讨论的公司分享我们专家团队特别为与中国相关的业务相应披露风险因素而专门起草的风险因素披露清单。